User:Alan Moreira Henrique/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 20: Line 20:
Clicking <scene name="/12/3456/Sample/1">here</scene> will colour Parkin from N-terminal (bluer) to C-terminal (redder) residues. <scene name='81/817543/All_pk_domains/1'>This link</scene> will highlight each domain of the protein.
Clicking <scene name="/12/3456/Sample/1">here</scene> will colour Parkin from N-terminal (bluer) to C-terminal (redder) residues. <scene name='81/817543/All_pk_domains/1'>This link</scene> will highlight each domain of the protein.
-
Parkin is a monomeric 465-residues long protein containing an Ubiquitin-like (Ubl) Domain, a RING0 domain, a RING1 domain, an In Between Rings (IBR) domain, a repressor (REP) element and a RING2 domain. Parkin is produced by the cell in an autoinhibited state. The <scene name='81/818543/Ubl/1'>Ubl domain</scene> maintains a compact <scene name='81/817543/Ring0-ring1/2'>RING0-RING1 interface</scene>. Phosphorylation of the <scene name='81/817543/Ser65_pk/3'>Ser65 residue</scene> in the Ubl domain leads to a change in conformation in the tertiary structure of the protein in the RING0-RING1 interface, which is optimized for pUb binding. However, both pUb and pUbl cannot be bound to parkin at the same time, which is consistent with the proposed allosteric loss of structure to the C-terminus of Helix H3 and IBR domain that would interfere with the Ubl-binding site.
+
Parkin is a monomeric 465-residues long protein containing an <span style="color:light green">Ubiquitin-like (Ubl)</span> domain, a <span style="color:dark blue">RING0</span> domain, a <span style="color:purple">RING1</span> domain, an <span style="color:black">In Between Rings (IBR)</span> domain, a <span style="color:yellow">repressor (REP)</span> element and a <span style="color:brown">RING2</span> domain. Parkin is produced by the cell in an autoinhibited state. The <scene name='81/818543/Ubl/1'>Ubl domain</scene> maintains a compact <scene name='81/817543/Ring0-ring1/2'>RING0-RING1 interface</scene>. Phosphorylation of the <scene name='81/817543/Ser65_pk/3'>Ser65 residue</scene> in the Ubl domain leads to a change in conformation in the tertiary structure of the protein in the RING0-RING1 interface, which is optimized for pUb binding. However, both pUb and pUbl cannot be bound to parkin at the same time, which is consistent with the proposed allosteric loss of structure to the C-terminus of Helix H3 and IBR domain that would interfere with the Ubl-binding site.
Besides its ubiquitin-ligase activity, Parkin also acts as a transcription factor, modulating, for instance, T[[P53]], PSEN1 and PSEN2. According to Duplan ''et al''. (2013), this function comes from a multidomain centered around <scene name='81/817543/Ring1-ibr-ring2/2'>RING1-IBR-RING2</scene>.
Besides its ubiquitin-ligase activity, Parkin also acts as a transcription factor, modulating, for instance, T[[P53]], PSEN1 and PSEN2. According to Duplan ''et al''. (2013), this function comes from a multidomain centered around <scene name='81/817543/Ring1-ibr-ring2/2'>RING1-IBR-RING2</scene>.

Revision as of 22:59, 16 June 2019

Parkin

Parkin (PDB code: 5c1z)

Drag the structure with the mouse to rotate

References

Kumar, A., Aguirre, J.D., Condos, T.E., Martinez-Torres, R.J., Chaugule, V.K., Toth, R., Sundaramoorthy, R., Mercier, P., Knebel, A., Spratt, D.E., Barber, K.R., Shaw, G.S., Walden, H. Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. (2015) Embo J. 34: 2506-2521 Duplan , E., Sevalle, J., Viotti, J., Goiranm T., Bauer, C., Renbaum, P., Levy-Lahad, E., Gautier, C. A., Corti, O., Leroudier, N., Checler, F., da Costa, C. A. (2013) Parkin differently regulates Presenilin-1 and Presenilin-2 functions by direct control of their promoter transcription. J. Mol. Biol. 5, 132-142.

Proteopedia Page Contributors and Editors (what is this?)

Alan Moreira Henrique

Personal tools